Patents by Inventor Francesca CACCURI

Francesca CACCURI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES WITH ANTI-ANGIOGENIC ACTIVITY
    Publication number: 20240382555
    Abstract: The present invention relates to a peptide of length equal to or less than 5 amino acids, or a derivative thereof, comprising the sequence DKY, preferably XDKY (SEQ ID No. 7) or DKYX (SEQ ID No. 8), or the sequence DRY, preferably XDRY (SEQ ID No. 9) or DRYX (SEQ ID No. 10), where X is any amino acid, for use as a drug, particularly for use in the treatment of a disorder resulting from pathological angiogenesis, and a pharmaceutical composition comprising it together with at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: September 8, 2022
    Publication date: November 21, 2024
    Applicant: CHEIRONTECH S.r.l.
    Inventors: Francesca CACCURI, Arnaldo CARUSO
  • PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY
    Publication number: 20240091306
    Abstract: The present invention relates to a peptide, or derivative thereof, having length equal to or lower than (30) amino acids, and comprising any one of SEQ ID Nos. 2, 3, 9, 10, 13, 14, 15, 16, 17, 18, or a conservative variant thereof, for use as a medicament, preferably for use in the treatment of conditions associated to/caused by deficient angiogenesis or conditions beneficing from increased angiogenesis.
    Type: Application
    Filed: September 6, 2021
    Publication date: March 21, 2024
    Inventors: Arnaldo CARUSO, Francesca CACCURI
  • USE OF THE U94 MOLECULE OF HUMAN HERPESVIRUS 6 AND DERIVATIVES THEREOF TO INCREASE OR INDUCE THE EXPRESSION OF THE HLA-G MOLECULE
    Publication number: 20210246456
    Abstract: A method of enhancing or inducing the expression of the HLA-G molecule by human cells is provided. The method includes administering the human Herpesvirus 6 U94 molecule or a derivative thereof, or a gene expression vector including and expressing the human Herpesvirus 6 U94 gene to a patient in need thereof or to an in vitro cell, tissue, or organ culture.
    Type: Application
    Filed: June 7, 2019
    Publication date: August 12, 2021
    Inventors: Arnaldo CARUSO, Roberta RIZZO, Dario DI LUCA, Elisabetta CASELLI, Francesca CACCURI